Dr. Sonja Krösser joined Novaliq in 2014. In her current role as VP Preclinical and Clinical Development she is responsible for leading development teams, progressing drug candidates from candidate selection through preclinical development into clinical development and for the clinical and regulatory strategy.
Before assuming her role at Novaliq, Dr Krösser worked in different leadership roles at Merck KGaA, focusing on translational medicine and PK/PD as well as modeling and simulation analysis within clinical development. Her experience comprises projects across all development stages from phase 0 to phase 4, including both NCE and NBE projects in different therapeutic areas. Since 2014 she has specialized in ophthalmology, in particular in Dry Eye Disease.
She studied pharmacy and received her PhD in Microbiology from the Ruperto Carlo University Heidelberg, Germany.
Sign up to view 0 direct reports
Get started